126 related articles for article (PubMed ID: 6685826)
1. Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 months.
Murugaiah K; Theodorou A; Jenner P; Marsden CD
Neuroscience; 1983 Nov; 10(3):811-9. PubMed ID: 6685826
[TBL] [Abstract][Full Text] [Related]
2. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
Murugaiah K; Fleminger S; Hall MD; Theodorou A; Jenner P; Marsden CD
Neuropharmacology; 1984 Jun; 23(6):599-609. PubMed ID: 6540376
[TBL] [Abstract][Full Text] [Related]
3. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
[TBL] [Abstract][Full Text] [Related]
4. Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptors.
Murugaiah K; Mann S; Theodorou AE; Jenner P; Marsden CD
Life Sci; 1982 Jul; 31(2):181-8. PubMed ID: 6889662
[TBL] [Abstract][Full Text] [Related]
5. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.
Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
Psychopharmacology (Berl); 1985; 86(1-2):228-32. PubMed ID: 3927361
[TBL] [Abstract][Full Text] [Related]
6. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Psychopharmacology (Berl); 1980; 69(3):227-33. PubMed ID: 6774362
[TBL] [Abstract][Full Text] [Related]
7. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
8. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
[TBL] [Abstract][Full Text] [Related]
9. Effects of continuous administration for 12 months of amine-depleting drugs and chlorpromazine on striatal dopamine function in the rat.
Hong M; Kilpatrick GJ; Jenner P; Marsden CD
Neuropharmacology; 1987 Aug; 26(8):1061-9. PubMed ID: 2889161
[TBL] [Abstract][Full Text] [Related]
10. Sequelae of 6 months continuous administration of cis(Z)-and trans(E)-flupenthixol in the rat.
Waddington JL; Gamble SJ; Bourne RC
Eur J Pharmacol; 1981 Feb; 69(4):511-3. PubMed ID: 7195814
[TBL] [Abstract][Full Text] [Related]
11. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
[TBL] [Abstract][Full Text] [Related]
12. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Eur J Pharmacol; 1980 May; 63(2-3):135-44. PubMed ID: 6103813
[TBL] [Abstract][Full Text] [Related]
13. Suppression of exploratory locomotor activity and increase in dopamine turnover following the local application of cis-flupenthixol into limbic projection areas of the rat striatum.
Ahlenius S; Hillegaart V; Thorell G; Magnusson O; Fowler CJ
Brain Res; 1987 Jan; 402(1):131-8. PubMed ID: 3828778
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
15. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
16. Irreversible blockade of striatal dopamine receptors in vivo by a derivative of alpha-flupenthixol.
Schuster DI; Holden WL; Narula AP; Murphy RB
Eur J Pharmacol; 1982 Feb; 77(4):313-6. PubMed ID: 7060641
[TBL] [Abstract][Full Text] [Related]
17. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
Clow A; Jenner P; Theodorou A; Marsden CD
Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
[No Abstract] [Full Text] [Related]
18. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
Akiyama K; Sato M; Otsuki S
Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
[TBL] [Abstract][Full Text] [Related]
19. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
Cross AJ; Waddington JL
Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
[TBL] [Abstract][Full Text] [Related]
20. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
Chivers JK; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
